114 related articles for article (PubMed ID: 7550016)
21. Influence of GYKI-13504, a new antioestrogen, on the responsiveness of isolated uterus removed from oestradiol pretreated rats to PGF2 alpha.
Borvendég J; Anheuer Z
Exp Clin Endocrinol; 1985 Dec; 86(3):368-70. PubMed ID: 3867510
[TBL] [Abstract][Full Text] [Related]
22. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Kawamura I; Mizota T; Kondo N; Shimomura K; Kohsaka M
Jpn J Pharmacol; 1991 Oct; 57(2):215-24. PubMed ID: 1812300
[TBL] [Abstract][Full Text] [Related]
23. Studies with 17 beta(16 alpha-[125i]iodo)-estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors.
Gatley SJ; Shaughnessy WJ; Inhorn L; Leiberman LM
J Nucl Med; 1981 May; 22(5):459-64. PubMed ID: 7218023
[TBL] [Abstract][Full Text] [Related]
24. E-17 alpha[125I]iodovinylestradiol: an estrogen-receptor-seeking radiopharmaceutical.
Hanson RN; Seitz DE; Botarro JC
J Nucl Med; 1982 May; 23(5):431-6. PubMed ID: 7077398
[TBL] [Abstract][Full Text] [Related]
25. In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen.
Löser R; Seibel K; Roos W; Eppenberger U
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):985-90. PubMed ID: 4043181
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat.
Ma XL; Gao F; Yao CL; Chen J; Lopez BL; Christopher TA; Disa J; Gu JL; Ohlstein EH; Yue TL
J Pharmacol Exp Ther; 2000 Nov; 295(2):786-92. PubMed ID: 11046119
[TBL] [Abstract][Full Text] [Related]
27. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.
Jordan VC; Collins MM; Rowsby L; Prestwich G
J Endocrinol; 1977 Nov; 75(2):305-16. PubMed ID: 591813
[TBL] [Abstract][Full Text] [Related]
28.
Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
[TBL] [Abstract][Full Text] [Related]
29. Histologic changes in ovary, uterus, vagina, and mammary gland of mature beagle dogs treated with the SERM idoxifene.
Rehm S; Solleveld HA; Portelli ST; Wier PJ
Birth Defects Res B Dev Reprod Toxicol; 2007 Jun; 80(3):225-32. PubMed ID: 17570126
[TBL] [Abstract][Full Text] [Related]
30. A new triphenylethylene compound, Fc-1157a. I. Hormonal effects.
Kallio S; Kangas L; Blanco G; Johansson R; Karjalainen A; Perilä M; Pippo I; Sundquist H; Södervall M; Toivola R
Cancer Chemother Pharmacol; 1986; 17(2):103-8. PubMed ID: 2941176
[TBL] [Abstract][Full Text] [Related]
31. Investigations of droloxifene and other hormone manipulations on N-nitrosomethylurea-induced rat mammary tumours. 1. Influence on tumour growth.
Winterfeld G; Hauff P; Görlich M; Arnold W; Fichtner I; Staab HJ
J Cancer Res Clin Oncol; 1992; 119(2):91-6. PubMed ID: 1429831
[TBL] [Abstract][Full Text] [Related]
32. Uptake of radiolabelled tyrosine and iodo-methyl tyrosine in experimental rat tumours: influence of blood flow and tumour growth rate.
Carnochan P; Deehan B; Trivedi M; Tombs A; Sandle J; Ott R
J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):92-5. PubMed ID: 7632776
[TBL] [Abstract][Full Text] [Related]
33. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
Wei LL; Mangel WF; Katzenellenbogen BS
J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
[TBL] [Abstract][Full Text] [Related]
34. Screening procedure for the development of mammary tumour-inhibiting anti-oestrogens.
Hartmann RW
Cancer Treat Rev; 1984 Mar; 11 Suppl A():155-61. PubMed ID: 6329512
[No Abstract] [Full Text] [Related]
35. Investigations of droloxifene and other hormonal manipulations on N-nitrosomethylurea-induced rat mammary tumours. 2. Influence on oestrogen receptor.
Görlich M; Winterfeld G; Hauff P; Arnold W; Fichtner I; Staab HJ
J Cancer Res Clin Oncol; 1992; 119(2):97-100. PubMed ID: 1429832
[TBL] [Abstract][Full Text] [Related]
36. Biodistribution of a novel antiestrogen (Analog II) in the mouse and rat.
Griffin MT; Pento JT; Magarian RA; Mousissian GK; Basmadjian GP
Endocr Res; 1990; 16(2):269-82. PubMed ID: 2344839
[TBL] [Abstract][Full Text] [Related]
37. Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.
Wakeling AE; Valcaccia B; Newboult E; Green LR
J Steroid Biochem; 1984 Jan; 20(1):111-20. PubMed ID: 6538611
[TBL] [Abstract][Full Text] [Related]
38. 99m Tc-glycopeptide: synthesis, biodistribution and imaging in breast tumor-bearing rodents.
Wei IC; Tsao N; Huang YH; Ho YS; Wu CC; Yu DF; Yang DJ
Appl Radiat Isot; 2008 Mar; 66(3):320-31. PubMed ID: 18036826
[TBL] [Abstract][Full Text] [Related]
39. Antiproliferative effects of idoxifene in a placebo-controlled trial in primary human breast cancer.
Dowsett M; Dixon JM; Horgan K; Salter J; Hills M; Harvey E
Clin Cancer Res; 2000 Jun; 6(6):2260-7. PubMed ID: 10873076
[TBL] [Abstract][Full Text] [Related]
40. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
Ip MM; Milholland RJ; Rosen F; Kim U
Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
